Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

MEDVi vs PlushCare

PlushCare costs $100 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
MEDVi logo

MEDVi

7.1
★★★★☆3.6/5

Best for: knowing which pharmacy fills the vial: it names Triad Rx

Visit MEDVi →
VS
PlushCare logo

PlushCare

6.4
★★★☆☆3.2/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit PlushCare →

If you are choosing between MEDVi and PlushCare, the first difference is cost: PlushCare is $100 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. MEDVi leads our six-part score, 7.1 to 6.4. One of the two has an FDA warning letter on record, covered below.

MEDVi vs PlushCare price

PlushCare is the cheaper way in: $149 a month against $249 a month at MEDVi. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.

Drug by drug: Semaglutide is cheaper at PlushCare ($149 a month vs $249 a month).

Medications and formats

Both sell semaglutide; only PlushCare lists tirzepatide.

On format they match: each offers compounded injections.

Where each one treats patients

MEDVi lists 48 states, and PlushCare lists 50 states.

They overlap in 48 states. PlushCare alone covers Mississippi and North Dakota.

Pricing

MEDVi

Compounded GLP-1 Injection (weekly)Compounded
$299$179/mo
Save 40% right now
semaglutide

Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.

Compounded GLP-1 Tablets (daily dissolvable)Compounded
$249/mo
semaglutide

Flat 'Starting at $249' — no intro discount shown.

Wegovy Pill / Wegovy Injection (membership fee only; medication cost not published)Brand-name
$99/mo
semaglutide

$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'

Zepbound Injection (membership fee only; medication cost not published)Brand-name
$99/mo
tirzepatide

$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.

PlushCare

StartingCompounded
$149/mo
semaglutide

Range up to $299/mo

StartingCompounded
$399/mo
tirzepatide

Range up to $599/mo

What each price covers

MEDVi's price also covers the clinician visit, the medication itself, shipping and coaching, which PlushCare does not claim.

MEDVi is silent on lab work.

PlushCare is silent on shipping and coaching.

That matters most for the drug: unless PlushCare confirms otherwise, budget for medication on top of its listed price.

MEDVi

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

PlushCare

Covered by the monthly price

Medication

Charged on top

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Charged on top

Coaching

Not stated

Where each one scores higher

Overall, MEDVi scores 7.1 and PlushCare 6.4 out of 10.

MEDVi is stronger on user experience (8.0 vs 7.0) and support (8.5 vs 0.0).

PlushCare is stronger on trust & safety (7.5 vs 6.0).

Value, effectiveness and accessibility are within half a point.

How we score

MEDVi

7.1/10

Overall

PlushCare

6.4/10

Value25%

2.8A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.0

Trust & Safety15%

6.0A
vs
B
7.5

Accessibility10%

9.7A
vs
B
10.0

Support10%

8.5A
vs
B
0.0

FDA warning letters

The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.

PlushCare has no FDA warning letter on record with us.

Features & Coverage

FeatureMEDViPlushCare
Starting Price$249/mo✓$149/mo
Features7 features✓8 features
States Available48✓50
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About MEDVi

Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.

Read our full MEDVi review →

About PlushCare

PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.

Read our full PlushCare review →

Pros & Cons

MEDVi

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves 48 states
  • Names 3 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

PlushCare

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • Serves all 50 states
  • We found no FDA warning letters issued to PlushCare
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
  • Baseline bloodwork is required before a prescription

Watch-outs

  • Not included in the monthly price: medication, clinician visits, lab work
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: MEDVi

MEDVi wins this one, 7.1 to 6.4, above all for knowing which pharmacy fills the vial: it names Triad Rx. PlushCare undercuts it by $100 a month, so if the monthly bill is what decides it, PlushCare is the pick. PlushCare fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose MEDVi if…

You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.

Choose PlushCare if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

MEDVi vs PlushCare: FAQ

PlushCare. It starts at $149 a month; MEDVi starts at $249 a month, $100 more per month.
Yes, both sell semaglutide. PlushCare adds tirzepatide.
PlushCare: 50 states against 48, with 48 in common.
Only MEDVi includes the clinician visit, the medication itself, shipping and coaching.
MEDVi has an open FDA warning letter from February 20, 2026. PlushCare has none.
No. Neither MEDVi nor PlushCare pays us anything.

Or see the full category ranking.